These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of tibolone on endogenous nitric oxide (nitrite/nitrate levels) in postmenopausal women.
    Author: Akgül C, Canbaz M, Vural P.
    Journal: Int J Fertil Womens Med; 2002; 47(1):13-7. PubMed ID: 11900269.
    Abstract:
    OBJECTIVE: To observe the effects of hormone replacement therapy with 2.5 mg/day tibolone for 6 months upon plasma nitrite/nitrate (end products of nitric oxide metabolism) in postmenopausal women. PATIENTS AND METHODS: The study involved 24 healthy postmenopausal women treated with tibolone (2.5 mg/day for 6 months) and 20 postmenopausal women who received placebo. Plasma nitrite/nitrate levels were measured with the Griess reaction. Statistical significance was analyzed by the Mann-Whitney U test and Pearson correlation analysis. RESULTS: The mean baseline concentrations of nitrite/nitrate were similar in both treated and placebo groups. Tibolone treatment decreased plasma nitrite/nitrate levels. CONCLUSIONS: We suggest that because of its androgenic and progestogenic actions, tibolone diminishes nitrite/nitrate levels. Also our data provide evidence for the existence of increased (1/3 of subjects, n = 8) and reduced (2/3 of subjects, n = 16) nitrite/nitrate levels in response to tibolone treatment. Clearly, further studies are necessary to establish a risk/benefit ratio for tibolone in view of its effects on nitric oxide metabolism.
    [Abstract] [Full Text] [Related] [New Search]